{"id":{"repo_id":"rowan","oai_identifier":"oai:rdw.rowan.edu:etd-3854"},"canonical_url":"https://search.ndltd.org/etd/rowan/oai:rdw.rowan.edu:etd-3854","repository":{"repo_id":"rowan","name":"Rowan University","base_url":"https://rdw.rowan.edu/do/oai/"},"display":{"title":"The relation between hyperlipidemia, hypertension, and downstream cognitive and neuroanatomical function","abstract":"Objective: Cardiovascular risks (CVR) such as hypertension and hyperlipidemia play a critical role in the emergence of dementia syndromes. Medication to treat CVR may not obviate downstream risk for cognitive change. Methods: To examine the relation between history of treatment with medications to treat CVR and cognitive outcomes, participants were seen at time points ~7 years apart, completed neuropsychological evaluations, assessed for history of treatment with medication associated with hypertension and hyperlipidemia as indicators of CVR, and classified into 3 groups: Not Treated, Inconsistently Treated, and Consistently Treated. Regression models associating neuropsychological outcome measures of cognition and CVR were explored and refined within a \"test dataset,\" and analyses were replicated using an independent \"validation dataset.\" Result: Most outcome measures were not significant, including episodic memory and executive tests. A main effect was found for hypertension for the Similarities subtest and the Digit Symbol Test; participants with no hypertension treatment history obtained better scores compared to other groups. While some measures were sensitive to impairment, MRI parameters were not associated with CVR indicators. Conclusion: Between group differences on outcome measures of cognition were detectable in the presence of well-controlled blood pressure, indicating that downstream cognitive consequences persist in the presence of intervention for hypertension.","abstract_html":"Objective: Cardiovascular risks (CVR) such as hypertension and hyperlipidemia play a critical role in the emergence of dementia syndromes. Medication to treat CVR may not obviate downstream risk for cognitive change. Methods: To examine the relation between history of treatment with medications to treat CVR and cognitive outcomes, participants were seen at time points ~7 years apart, completed neuropsychological evaluations, assessed for history of treatment with medication associated with hypertension and hyperlipidemia as indicators of CVR, and classified into 3 groups: Not Treated, Inconsistently Treated, and Consistently Treated. Regression models associating neuropsychological outcome measures of cognition and CVR were explored and refined within a &quot;test dataset,&quot; and analyses were replicated using an independent &quot;validation dataset.&quot; Result: Most outcome measures were not significant, including episodic memory and executive tests. A main effect was found for hypertension for the Similarities subtest and the Digit Symbol Test; participants with no hypertension treatment history obtained better scores compared to other groups. While some measures were sensitive to impairment, MRI parameters were not associated with CVR indicators. Conclusion: Between group differences on outcome measures of cognition were detectable in the presence of well-controlled blood pressure, indicating that downstream cognitive consequences persist in the presence of intervention for hypertension.","abstract_has_math":false,"creators":["Wasserman, Victor James"],"institution":null,"degree_name":"Doctor of Philosophy","degree_level":"Dissertation","degree_discipline":"Psychology","degree_department":null,"school":null,"contributors":["Arigo, Danielle","Libon, David J.","Fife, Dustin"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:59:18Z","subjects":["Alzheimer's Disease","Cognitive Impairment","Dementia","Neuropsychology","Vascular Dementia","Cardiovascular diseases in old age","Clinical Psychology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://rdw.rowan.edu/etd/2852","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://rdw.rowan.edu/etd/2852","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://rdw.rowan.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Ardw.rowan.edu%3Aetd-3854","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Arigo, Danielle","Libon, David J.","Fife, Dustin"]},{"key":"dc:creator","label":"Author","values":["Wasserman, Victor James"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2020-12-18T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2020-12-17T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Psychology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Alzheimer's Disease","Cognitive Impairment","Dementia","Neuropsychology","Vascular Dementia","Cardiovascular diseases in old age","Clinical Psychology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://rdw.rowan.edu/etd/2852"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Objective: Cardiovascular risks (CVR) such as hypertension and hyperlipidemia play a critical role in the emergence of dementia syndromes. Medication to treat CVR may not obviate downstream risk for cognitive change. Methods: To examine the relation between history of treatment with medications to treat CVR and cognitive outcomes, participants were seen at time points ~7 years apart, completed neuropsychological evaluations, assessed for history of treatment with medication associated with hypertension and hyperlipidemia as indicators of CVR, and classified into 3 groups: Not Treated, Inconsistently Treated, and Consistently Treated. Regression models associating neuropsychological outcome measures of cognition and CVR were explored and refined within a \"test dataset,\" and analyses were replicated using an independent \"validation dataset.\" Result: Most outcome measures were not significant, including episodic memory and executive tests. A main effect was found for hypertension for the Similarities subtest and the Digit Symbol Test; participants with no hypertension treatment history obtained better scores compared to other groups. While some measures were sensitive to impairment, MRI parameters were not associated with CVR indicators. Conclusion: Between group differences on outcome measures of cognition were detectable in the presence of well-controlled blood pressure, indicating that downstream cognitive consequences persist in the presence of intervention for hypertension."]},{"key":"dc:title","label":"Title","values":["The relation between hyperlipidemia, hypertension, and downstream cognitive and neuroanatomical function"]}]}],"canonical_facts":{"dc:contributor":["Arigo, Danielle","Libon, David J.","Fife, Dustin"],"dc:creator":["Wasserman, Victor James"],"dc:date.available":["2020-12-18T08:00:00Z"],"dc:date.created":["2020-12-17T08:00:00Z"],"dc:description.abstract":["Objective: Cardiovascular risks (CVR) such as hypertension and hyperlipidemia play a critical role in the emergence of dementia syndromes. Medication to treat CVR may not obviate downstream risk for cognitive change. Methods: To examine the relation between history of treatment with medications to treat CVR and cognitive outcomes, participants were seen at time points ~7 years apart, completed neuropsychological evaluations, assessed for history of treatment with medication associated with hypertension and hyperlipidemia as indicators of CVR, and classified into 3 groups: Not Treated, Inconsistently Treated, and Consistently Treated. Regression models associating neuropsychological outcome measures of cognition and CVR were explored and refined within a \"test dataset,\" and analyses were replicated using an independent \"validation dataset.\" Result: Most outcome measures were not significant, including episodic memory and executive tests. A main effect was found for hypertension for the Similarities subtest and the Digit Symbol Test; participants with no hypertension treatment history obtained better scores compared to other groups. While some measures were sensitive to impairment, MRI parameters were not associated with CVR indicators. Conclusion: Between group differences on outcome measures of cognition were detectable in the presence of well-controlled blood pressure, indicating that downstream cognitive consequences persist in the presence of intervention for hypertension."],"dc:identifier":["https://rdw.rowan.edu/etd/2852"],"dc:subject":["Alzheimer's Disease","Cognitive Impairment","Dementia","Neuropsychology","Vascular Dementia","Cardiovascular diseases in old age","Clinical Psychology"],"dc:title":["The relation between hyperlipidemia, hypertension, and downstream cognitive and neuroanatomical function"],"thesis:degree_discipline":["Psychology"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Doctor of Philosophy"]},"updated_at":"2026-11-19T08:59:18Z"}